From an Indian pharma perspective, I don't anticipate any sweeping ... broader adoption could lower prices over time. We are also focussed on obesity and diabetes, which will remain significant ...

This study uncovers the hepatic vagal nerve's influence on circadian food intake, presenting new avenues for obesity treatment through targeted interventions.

(Reuters) - U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk's highly in-demand drugs for ...

Frybread — a simple, versatile “comfort food” for many Indigenous communities — embodies the contradictions that have ...

Cinnamon is a lot more than just an aromatic spice. Besides being used as a traditional medicine for decades, consuming ...

Mount Nittany Health has introduced Kavita Goyal, MD, as a primary care and weight management provider. Dr. Goyal knew from a ...

A study reveals that 30 minutes of daily vigorous exercise may counteract some aging effects of sitting, highlighting the ...

Current health news highlights the expected high demand for Novo Nordisk's obesity drug in India, the need for personalized approaches in knee replacement surgeries, Gilead's notable financial ...

Popular weight-loss drug Wegovy maker Novo Nordisk expects high demand and acceptance for its anti-obesity drug, when ...

New CDC population data from 2023 show that in 23 states more than one in three adults (35 percent) has obesity. Before 2013, no state had an adult obesity prevalence at or above 35 percent. Currently ...

Viking Therapeutics shares climbed 9% on Monday after the drug developer's oral obesity treatment helped reduce body weight ...

Among adults, the most common conditions were hypertension, obesity, chronic metabolic disease ... the Dr. Susan and Susette ...